U.S. Consumers Foot the Bill for Cheap Drugs in Europe and Canada

Big Pharma bases its drug prices around the world on what it thinks the market can bear.

A few days ago, when I remarked that U.S. pharmaceutical prices subsidize much of the research that benefits the rest of the world, I got various forms of push back, so it seems worth running, briefly, through the logic:

To continue reading this article you must be a Bloomberg Professional Service Subscriber.